Latest Financial Position News

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Auric Mining has reported final production results from its Munda Starter Pit, delivering 8,886 ounces of gold; 46% above budget; and confirming a larger, higher-grade resource than previously estimated.

ChemX Materials has formalised a $1.2 million unsecured loan with independent investor Ovay Pty Ltd to support its working capital amid ongoing restructuring, with the loan set to convert to shares upon re-listing.

Austal Limited has addressed ASX concerns over its half-year financial report, confirming compliance with accounting standards despite a qualified audit opinion linked to US Department of Defense contractual relief revenue.

Anax Metals has successfully raised $10 million through a two-tranche placement, strengthening its financial position ahead of critical funding and development milestones for the Whim Creek Copper Project.

Viridis Mining and Minerals has raised AU$25 million through a heavily oversubscribed placement, bolstering its cash position to approximately AU$76 million as it advances the Colossus Rare Earth Project towards a Final Investment Decision in Q3 2026.

Gateway Mining has identified the Rubicon prospect within its Yandal Gold Project, revealing significant gold mineralisation over a 700-metre strike. Early drilling results suggest potential for multiple high-grade lodes, with further assays pending.

OZZ Resources Limited has announced a fully underwritten entitlement offer to raise approximately $1.07 million, aiming to convert debt and fund project opportunities while addressing its ongoing ASX suspension. The offer carries significant risks including potential dilution and the threat of delisting if compliance is not met by June 2026.

Argenica Therapeutics has secured a nearly $4 million R&D tax incentive rebate for FY25, strengthening its cash position as it prepares for a pivotal Phase 2b trial of its neuroprotective peptide ARG-007.

Resonance Health has received a $732,851 refund from the Australian Taxation Office, reflecting its FY2025 R&D tax incentive claim net of income tax payable. This cash inflow strengthens the company’s financial position ahead of its March quarterly report.

MaxiPARTS Limited has announced a fully franked ordinary dividend of AUD 0.0415 per share for the half-year ending December 2025, alongside a confirmed dividend reinvestment plan price of AUD 1.94 per share.

Renascor Resources has completed construction of its Purified Spherical Graphite demonstration facility in Adelaide, marking a pivotal step towards commercialising its innovative HF-free purification process for battery anode materials.